ARTICLE | Regulation
Legacy in place, FDA’s Woodcock to retire in early 2024
In more than three decades at FDA, Janet Woodcock has reshaped the way drugs are regulated and developed
November 16, 2023 8:52 PM UTC
Janet Woodcock, who for three decades has been the most influential regulator of biomedical products worldwide, will retire from FDA in early 2024.
Woodcock joined FDA in 1986 as director of the Division of Biological Investigational New Drugs at the Center for Biologics Research and Evaluation (CBER). She has served as director of the Center for Drug Evaluation and Research (CDER), deputy FDA commissioner and CMO, acting FDA commissioner, and most recently principal deputy commissioner. ...